Remarkably, when compared to the PCOS group, the combined treatment group displayed a significant reduction in serum levels of T, E2, FSH, LH, and AMH, with these reductions being more pronounced than those observed in mice treated with astaxanthin or CUR alone (Figure 4A–E, p < 0.001). The gene discussed is PLOD1; the disease is polycystic ovary syndrome.